Skip to content
Peptide research

Decapeptide-12

Also known as Lumixyl
Category
Skin & Cosmetic
Administration routes
Topical
Regulatory status
Cosmetic ingredient

What it is

A synthetic peptide used in topical skincare to fade melasma and dark spots by blocking tyrosinase, the enzyme that makes melanin. Its hydroquinone comparisons are mostly lab findings, and the human case rests on small, short trials at low doses, so real-world evidence is thin. Risks are mild (irritation, sun sensitivity), but long-term human safety data is limited. It is a cosmetic ingredient, not an FDA-approved drug, and quality varies among unregulated products sold online.

Read Full record

Studied uses & evidence

Studied uses(10)

  • Potent tyrosinase inhibition: Up to 17 times more effective than hydroquinone at inhibiting the melanin-producing enzyme tyrosinase

    Speculative

    One in vitro enzyme study; the 17x figure is for mushroom tyrosinase, not human skin, never tested in vivo.

  • Skin brightening: in vitro studies show reduced melanin production

    Medium

    A single in vitro study found 43% melanin reduction in human melanocytes at 100 micromolar.

  • One uncontrolled multi-product regimen study reported a 60% mean MASI decrease after 16 weeks.

    Low

    Reported in an uncontrolled multi-product regimen; a small double-blind pilot also showed improvement, effect size unclear.

Evidence limits

Evidence Level
Moderate

Benefits = confidence in the evidence: High · Medium · Low · Speculative (High requires human randomized trials for that specific benefit)

Cautions & risk summary

General cautions

  • Pregnancy or breastfeeding

    Absolute

    No human reproductive safety data exists for this peptide. Effects on fetal development are unknown.

  • Children under 18

    Absolute

    No pediatric safety data. Not recommended for use in minors.

  • Known hypersensitivity

    Absolute

    Discontinue immediately if allergic reaction occurs (rash, swelling, difficulty breathing).

Risk summary(11)

Risks = level of concern: High · Moderate · Low · Theoretical

  • Mild skin irritation (uncommon)

    Low
  • Temporary redness at application site (rare)

    Low
  • Mild itching or dryness (uncommon)

    Low
  • Potential increased sun sensitivity (use sunscreen)

    Theoretical
  • Known allergy or sensitivity to any component of the peptide

    Moderate
  • Application on broken, irritated, or infected skin

    Moderate
  • Open wounds or active skin infections at treatment site

    Moderate
  • safety_profile

    Low
  • Apply sunscreen when using this product as skin may be more sensitive to UV exposure

    Moderate
  • Discontinue use if significant irritation or allergic reaction occurs

    Low
  • Patch test recommended for individuals with sensitive skin or history of allergic reactions to topical products

    Low
Safety & interactions in Full record

Further reading

Read Full record

This is educational content compiled from published research, not medical advice. Always consult a licensed healthcare provider before using any peptide. Medical disclaimer

Compiled from published research indexed through March 2026.